Treatments

Pfizer Giving Stanford $3 Million Grant For Improving Doctors' Training

A leading medical school that said a few years ago it wouldn't take industry money to fund specific continuing education courses for doctors and a big drugmaker that said it would no longer give money to for-profit education companies have struck a $3 million deal to find new ways to keep doctors' knowledge up to date.

Yup. Pfizer, the world's largest drug company, is giving Stanford University, a three-year, no-strings-attached grant to teach doctors about advances in medicine after they're in practice, the New York Times reported.

Stanford docs will pick the topics. Some possibilities, according to a Stanford statement, include reducing surgical infections, better diabetes management and getting patients to use smoking-cessation programs.

The educational programs are likely to make use of all sorts of simulation, a Stanford strength, rather than lectures to make their points.

Columbia's David Rothman, a frequent critic of industry's influence medical education told the Times, "It's fair to say Stanford is once again leading the pack." But Dr. Adriane Fugh-Berman, who runs the project PharmedOut to counter industry marketing, said, "the announcement is self-satirizing."

Comments

 

Please keep your community civil. All comments must follow the NPR.org Community rules and terms of use, and will be moderated prior to posting. NPR reserves the right to use the comments we receive, in whole or in part, and to use the commenter's name and location, in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.